Case year old single gay man First contact with clinic in Nov Unprotected sex 60 hours previously Received PEP Remained HIV-negative

Size: px
Start display at page:

Download "Case year old single gay man First contact with clinic in Nov Unprotected sex 60 hours previously Received PEP Remained HIV-negative"

Transcription

1 PrEP Case Studies

2 Case 1 62 year old single gay man First contact with clinic in Nov 2011 Unprotected sex 60 hours previously Received PEP Remained HIV-negative Repeat exposures requiring PEP in 2013, 2014 and 2015 Primary sex partner is HIV-positive on ART Enquired about PrEP in July 2015

3 Case 1 Does he need PrEP? Yes! Ongoing exposure risk not using condoms constantly Confirmation of HIV-negative status? HIV fourth generation negative previously and on this visit Sexual history last possible exposure 10 days ago Clinical assessment current URTI (presumed viral) What other baseline investigations are required? Creatinine and creatinine clearance (>60 ml/min) Hepatitis B surface antigen and antibody STI screen

4 Case 1: Results HIV rapid test negative Creatinine 98 umol/l MDRD GFR >60 ml/min HBsAg-negative HBsAb-positive Do you start PrEP? Delay PrEP and review in 2-4 weeks Counselling / condoms / lubricant 2 Week visit: HIV-negative and clinically well Start PrEP

5 Case 1: 1 Month Follow Up Correct pill-taking confirmed No current STIs Ongoing potential HIV exposures Side effects settled after 5 days What tests are required? Confirmation of HIV-negative status STI screening? Repeat creatinine and creatinine clearance Creatinine 117 Cr Cl 56

6 Case 1: Ongoing management Stop PrEP Client is a doctor! Counselled about risks and benefits Ongoing high risk of HIV exposure Unwilling to increase condom use Social event with excess alcohol the day before monitoring occurred Chooses not to stop but to increase monitoring

7 Case 1: Ongoing management Search for alternative causes of renal dysfunction Not hypertensive Normal random glucose Total fasted cholesterol 5.3 No nephrotoxic agents (e.g. no NSAIDs) No family history Normal urine dipstix (no proteinuria) Repeat Renal Function: Creatinine 103 Cr Cl >60

8 Case 1: 3 Month Follow Up Correct pill taking confirmed No current STIs Repeat creatinine Scripted 3 months of PrEP Creatinine 135 Cr Cl 48 Stop PrEP Counselling/advice about HIV prevention

9 Case 1: Outcome Patient does not want to stop PrEP Elected to continue despite medical advice with close monitoring Renal function has improved slightly and stabilised (Cr Cl approx 55) Increasing comfort level that tenofovirinduced renal dysfunction may plateau AGAINST current guidelines!

10 Case 2 48 year old MSM from Cape Town Single No past medical history of note Sexual history About 5 partners per month Sex at a sex-on-site venue once per week Bottom (preference for receptive anal sex) Condom use about half the time No prior STI diagnosis No regular GP

11 Case 2 Complains of 1 month severe fatigue 2 weeks of jaundice and itch Jaundiced, not pale, not acutely unwell No signs of chronic liver disease What is your differential diagnosis? What tests would you perform?

12 Case 2: Results Liver Function Test Result Total bilirubin 58 Conjugated bilirubin 29 ALP 216 ALT 1429 AST 1706 Test Hepatitis A IgM and IgG Hepatitis B surface antigen Hepatitis B surface antibody Hepatitis B E antigen Rapid syphilis Results Negative Positive Negative Positive Positive

13 Case 2: Follow up Referred to tertiary hospital liver clinic Conservative management of viral hepatitis Clinically well LFTs remained elevated (ALT 42, AST 45) Participant requests PrEP

14 Case 2 Does he need PrEP? Yes! Ongoing exposure risk not using condoms consistently Confirmation of HIV-negative status? HIV fourth generation negative previously and on this visit Sexual history No recent possible HIV exposures Clinical assessment clinically well What other baseline investigations are required? Creatinine and creatinine clearance (>60 ml/min) : normal Liver USS : normal

15 Case 2 Would you prescribe PrEP? Yes! Two indications for tenofovir / emtricitabine Ongoing concern of risk of transmission of sexual viruses Increased condom use but still high risk behaviours Most studies to date have excluded HepB + people from PrEP studies. Why? Risk of LFT flare if stop HBV treatment if chooses to cycle off PrEP. One patient in a clinical trial has died after worsening of chronic hepatitis B on stopping PrEP

16 The safety of PrEPin the presence of hepatitis B infection HBV is common in countries that don t vaccinate HBV common in South Africa 20% of incident infections become chronic TDF/FTC suppresses HBV and thus acts as treatment Concern about flares if stop TDF/FTC or resistance develops PrEP exclusion

17 The safety of PrEPin the presence of hepatitis B infection Sub-study of HBV + participants in iprex 13/2499 (0,5%) chronic HBV 6 were in the group assigned TDF/FTC 0/6 experienced flares after stopping PrEP 2 participants had evidence of acute HBV and started PrEP severe elevatedlfts (as expected in acute infection) which settled and both cleared virus and became immune

18 Case 2: Outcome Ineligible for sponsored PrEP in Cape Town Started private sector PrEP Using generic medications Hepatitis B viral load now undetectable Liver function tests completely normal Normal renal function Good pill taking Remains HIV-negative

19 Sex Worker Case Studies

20 Case Study: Lebo Lebo is a 27 year old woman living in Hillbrow. She comes into the clinic with complaints of an STI. She works as a part-time domestic helper during the day and she also works at a bar some evenings. She has two small children, and her husband has passed. She is not on contraception as she does not like the side effects. She wants to take an HIV test and look at potential options for contraception with low side effects. She also wants a box of condoms, because after some conversation, she admits she has a couple of sexual partners. 263

21 Case Study: Lebo What are the steps you would undertake to further assess what Lebo might need in terms of contraception and HIV prevention? What messages will you give her around risk and prevention of unwanted pregnancies, STIs, and HIV? Do you think Lebo should consider PrEP as an HIV prevention option? Why or why not? If you give her PrEP as an option, what will you tell her about taking the drug (e.g. side effects and adherence)? 264

22 Candice is an 18 year old transgender woman Her parents have died Case Study: Candice She engages in sex work to support her young brother. She is worried about recurring STIs and has been to the clinic previously to start PrEP. She admits that she only started taking her PrEP after two weeks of getting the script filled and has not been very consistent in taking the pills every day. She has experienced some very minor side effects (upset stomach), and is unsure about continuing to take PrEP. 265

23 Case Study: Candice Whose decision is it as to whether Candice should continue PrEP? What messages will you give her around risk and adherence to PrEP? How can you help her decide whether to continue PrEP and what strategies she could use? What are the steps you would undertake to further assess what Candice should do in terms of preventing HIV and STIs? 266

24 Case Study: Thandi Thandiis a 28 year old woman living in Hillbrow She has been taking PrEP for six months. She previously told you she is a sex worker and she only uses condoms for contraception. When she comes to the clinic for her next check-in, she tests positive for pregnancy. At this visit, she tells you she is unsure if she is going to terminate the pregnancy because of the risk of PrEP effects on her baby. How do you counsel her about continuing PrEP use? 267

25 Case Study: Thandi Thandihas been taking PrEP for six months. When she comes to the clinic for her next check-in, she tests positive for pregnancy. She previously told you she is a sex worker. At this visit, she tells you she is unsure if she is going to terminate the pregnancy because of her current life circumstances. She decides to go off of PrEP, and deliberate about whether she will terminate her pregnancy or not. She comes back to the clinic and tells you she ended up terminating and she wants to restart PrEP. What do you do at this point? Note: she has been offered contraception at every visit 268

26 Adolescents Case Studies

27 Case 1: Jackie Jackie is 15 and lives in an area where gangs and crime are rife. She has been raped once, so have many of her friends. Her mother brings her in the clinic to discuss the prevention against HIV and pregnancy. She also suspects her daughter and her boyfriend are having sex, although Jackie denies it. Her mother has heard about this PrEP pill and thinks this should be given to her daughter.

28 Case 1: Jackie What is your personal feeling about this? How would you handle this professionally? Is Jackie eligible for PrEP? What additional information do we need to confirm eligibility? What are her rights? what are her mother s right to protect her? What issues would you discuss with them?

29 Case 2: Lerato Leratois a 16 year old adolescent She is an orphan and has been brought up by her aunt, who sells alcohol as a means of income. Leratois sexually active and has a boyfriend She also does favours for her aunt's clients so that they can keep coming back. Her aunt is aware of that and advised Leratoto use an injection to prevent pregnancy. Her aunt does not believe Leratocan contract HIV from her customers because they are high profile and respectable men. Leratois, on the other hand, thinking of making extra money for herself by doing transactional sex with some of the customers

30 Case 2: Lerato Can Leratobe considered to be high risk from contracting HIV? Would she be eligible for PrEP? What prevention strategies can be recommended to Lerato other than prep? What are the possible disadvantages of PrEP for girls her someone aged 16?

31 Discordant Couple: Case Study 22 year old woman attends your CHC Previously well, no medical history of note Recently married Her husband his HIV positive and has been honest about his status Husband s CD4 count is 1000 cells/mm 3 She has been using condoms but her husband is not happy to continue using them

32 Discordant Couple: Case Study What HIV prevention strategies are applicable to this couple? Condoms and lube PEP PrEP TasP/ UTT

33 Discordant Couple: Follow Up Husband Advise treatment and link to care at nearest state ART facility Promote condom use Discussion that he should wait until he is virally suppressed before planning a family Wife comes to see you one month later Husband has not yet attended for ART Requests PrEP

34 Discordant Couple: Case Study Does she need PrEP? Yes! Ongoing exposure risk husband not keen on condoms and she may not have the ability to negotiate consistent condom use Confirmation of HIV-negative status? HIV fourth generation negative previously and on this visit What other baseline investigations are required? Creatinine and creatinine clearance (>60 ml/min) Hepatitis B surface antigen and antibody STI screen Pregnancy test! Advise contraception All results are favourable Start PrEP Advise contraception

35 Discordant Couple: Case Study All well at months 1, 3 and 6 Correct pill-taking Using condoms about 50% of the time Reports using oral contraceptive Husband started ART 4 weeks previously USS scan confirms viable 20 week male foetus

36 What do you do now? Do you stop PrEP? Mother Stop PrEP Ongoing HIV risk to mom (5% incidence in some studies) Continue PrEP Protects mom Baby Minimisesrisk to baby Risk of bone abnormalities but insufficient data MCC contra-indicates Truvada use for PrEP during pregnancy Tenofovir is FDA category B risk in pregnancy Lots of experience of use in pregnant HIV-positive mothers Case by case decision based on risks and benefits

37 Discordant Couple: Outcome Elected to stop PrEP Couple were prepared to use condoms consistently as long as not permanent Successful normal delivery Baby (and mom) remain HIV-negative Husband now on ART and VL LDL

PrEP application in the SA Context. Dr Kevi Naidu AWACC 07Oct2016

PrEP application in the SA Context. Dr Kevi Naidu AWACC 07Oct2016 PrEP application in the SA Context Dr Kevi Naidu AWACC 07Oct2016 Definition: Key Populations o Key populations are: Defined groups who, due to specific higher-risk behaviours, are Men at who increased

More information

South African Guidelines for the Safe Use of. Dr. Oscar Radebe

South African Guidelines for the Safe Use of. Dr. Oscar Radebe South African Guidelines for the Safe Use of PrEP in MSM Dr. Oscar Radebe Background Globally MSM(men who have sex with men) have been disproportionately at high risk of HIV transmission. Biological &

More information

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute PrEP for HIV Prevention Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the PrEP Guideline Raise awareness of PrEP among healthcare

More information

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes

More information

PrEP in the Real World: Clinical Case Studies

PrEP in the Real World: Clinical Case Studies PrEP in the Real World: Clinical Case Studies Kevin L. Ard, MD, MPH April 30, 2015 Massachusetts General Hospital, National LGBT Health Education Center Continuing Medical Education Disclosure Program

More information

PrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV.

PrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV. PrEP in Scotland PrEP PrEP PrEP PrEP is a combination pill that prevents HIV. 1 Contents Introduction 3 What is PrEP 3 Who should take PrEP 4 Getting PrEP in Scotland 5 Side effects and interactions with

More information

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) For Healthcare Providers About Emtricitabine/Tenofovir Disoproxil

More information

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa HPTN 075 Protocol Chair: Theo Sandfort New York State Psychiatric Institute and Columbia University

More information

Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers

Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers About emtricitabine/tenofovir disoproxil fumarate for HIV-1 PrEP

More information

HIV PrEP in Ireland. Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP

HIV PrEP in Ireland. Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP HIV PrEP in Ireland Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP The HSE Sexual Health and Crisis Pregnancy Programme (SHCPP) and the HIV PrEP working

More information

What?! Why?! Emergency Contraception. physical consequences. emotional consequences

What?! Why?! Emergency Contraception. physical consequences. emotional consequences HealthCHAT Emergency Contraception What?! Emergency contraception is a series of pills that can be taken by a woman to prevent pregnancy after having unprotected sex. Why?! Emergency contraception allows

More information

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP HIV: Pregnancy in Serodiscordant Couple Dr Chow TS ID Clinic HPP Sexual Reproductive Health and Rights The recognition of the sexual and reproductive health and rights (SRHR) of all individuals and couples

More information

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County PREVENTION OF HIV IN THE TIMES OF PREP Daniela Chiriboga, MD Florida Department of Health in Polk County MAKING THE CASE FOR PREVENTION The Epidemic in Florida Population in 2014: 19.6 million (3 rd in

More information

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep I M ENDING HIV PrEP PATIENT INFORMATION endinghiv.org.au/prep THIS BOOKLET PROVIDES YOU WITH INFORMATION ABOUT Pre-Exposure Prophylaxis (PrEP) for HIV. CONTENTS 06 Who will benefit from PrEP? 04 What is

More information

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017 HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland An update for registered practitioners September 2017 Key Messages HIV is a major public health challenge for Scotland with an annual average of 359

More information

Having Sex. Some people are heterosexual. Fact Sheet

Having Sex. Some people are heterosexual. Fact Sheet Fact Sheet Having Sex Sometimes people who are in a close relationship and like each other a lot, or love each other, like to kiss and cuddle. Sometimes they show how much they like or love each other

More information

If you are a man that ONLY has sex with women this may not be the brochure for you.

If you are a man that ONLY has sex with women this may not be the brochure for you. If you are a man that ONLY has sex with women this may not be the brochure for you. To find resources that best meet your needs check out the following website: http://www.cdc.gov/men Whether you are gay,

More information

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication For Healthcare Providers About TRUVADA for a PrEP Indication INDICATION AND PRESCRIBING CONSIDERATIONS TRUVADA,

More information

PrEP for Women. Together, we can change the course of the HIV epidemic one woman at a time.

PrEP for Women. Together, we can change the course of the HIV epidemic one woman at a time. PrEP for Women Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is PrEP? PrEP stands for Pre- Exposure Prophylaxis: Prophylaxis: Taking

More information

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE Sandyford Protocols MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE www.hiv-druginteractions.org If you require information on occupational exposure to blood borne viruses, including HIV, please refer to the

More information

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016 Case Studies in PrEP Management Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016 Continuing Medical Education Disclosure Program Faculty: Kevin

More information

Pre-exposure Prophylaxis and Primary Care

Pre-exposure Prophylaxis and Primary Care Pre-exposure Prophylaxis and Primary Care National Latino HIV and Hepatitis C Conference June 7 th, 2016 Allison Finkenbinder, MSN, WHNP-BC Denver Prevention Training Center Who s in the audience? Disclosures

More information

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs Fast-Track Your PrEP Knowledge Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs Session objectives Increase knowledge of the basics of PrEP and clinical procedures Identify financial

More information

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000. Disclosure PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION I have no financial interest in and/or affiliation with any external organizations in relation to this CE program. DaleMarie Vaughan, PharmD

More information

OR: Steps you can take in the clinic to prevent HIV infections

OR: Steps you can take in the clinic to prevent HIV infections Implementing Changes to Reduce HIV Incidence: Synergies between Public Health and Primary Care Kevin Ard, MD, MPH Brigham and Women s Hospital, Massachusetts General Hospital, and the Fenway Institute

More information

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect Counselling Should: Be sensitive, inclusive, and non-judgmental Recognize that behaviour change is difficult and human beings are not perfect Be presented as a personal choice Counselling should support

More information

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory

More information

UPDATE TRAINING ARV TREATMENT GUIDELINES TRAINERS CASE STUDIES & ANSWER GUIDE

UPDATE TRAINING ARV TREATMENT GUIDELINES TRAINERS CASE STUDIES & ANSWER GUIDE UPDATE TRAINING ARV TREATMENT GUIDELINES TRAINERS CASE STUDIES & ANSWER GUIDE 3/13/2013 Contents Group Work Instructions... 2 PMTCT... 3 Case Study 1: Unbooked Pregnant Women... 3 Case Study 2: First ANC

More information

PRECONCEPTION COUNSELING

PRECONCEPTION COUNSELING PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal

More information

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active?

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active? Essential Sexual Health Questions to Ask Adults Ask all of your adult patients the sexual health questions on this card. They will help you assess the patient s level of sexual risk and determine whether

More information

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication Training Guide for Healthcare Providers About TRUVADA for a PrEP indication to reduce the risk of sexually acquired HIV-1 infection in high-risk

More information

Attendees will be able to:

Attendees will be able to: A. Kay Kalousek, DO, MS, FACOFP kaysdroid@gmail.com April 21, 2017 Attendees will be able to: List strategies for prevention of HIV infection Explain the pharmacology of TDF/FTC related to PrEP Assess

More information

RADIO AS A TOOL IN COMMUNITY ENGAGEMENT AND EDUCATION

RADIO AS A TOOL IN COMMUNITY ENGAGEMENT AND EDUCATION Note to file: The author of this article (Joel Odondi) has been in charge of community education, recruitment of study participants and retention of enrolled participants in Kisumu site. This included

More information

Getting Prepped for PrEP. Ken Ho, MD, MPH World AIDS Day

Getting Prepped for PrEP. Ken Ho, MD, MPH World AIDS Day Getting Prepped for PrEP Ken Ho, MD, MPH World AIDS Day Objectives HIV epidemiology What is PrEP? Does it Work? Who gets PrEP? How do I prescribe PrEP What to do at the first visit? What to do at follow

More information

Family Planning and Sexually Transmitted. Infections, including HIV

Family Planning and Sexually Transmitted. Infections, including HIV Infections, including HIV Family Planning and Sexually Transmitted Introduction To protect themselves, people need correct information about sexually transmitted infections (STIs), including HIV. Women

More information

HIV Prevention Pearls

HIV Prevention Pearls HIV Prevention Pearls Meghan Rothenberger, MD Assistant Professor Division of Infectious Diseases University of Minnesota Director, Youth and AIDS Projects October 27, 2017 Disclosure Information I have

More information

PrEP and Behavioral Strategies for HIV Prevention. Douglas Krakower, MD January 30, 2014

PrEP and Behavioral Strategies for HIV Prevention. Douglas Krakower, MD January 30, 2014 PrEP and Behavioral Strategies for HIV Prevention Douglas Krakower, MD January 30, 2014 Potential Competing Interests Dr. Krakower: investigator-initiated research regarding HIV prevention National Institutes

More information

Treatment Trends for South African MSM. Kevin Rebe

Treatment Trends for South African MSM. Kevin Rebe Treatment Trends for South African MSM Kevin Rebe Why MSM? MSM are at high risk of HIV transmission and acquisition Identified in current NSP for targeted health services South Africa = 10.4 to 44.5% Increased

More information

GP Perspective about prescribing PEP & PrEP

GP Perspective about prescribing PEP & PrEP GP Perspective about prescribing PEP & PrEP Dr Garsing Wong, Auckland Central Medical and Health Centre, 326/28 College Hill, Freemans Bay, Auckland 1011 akcentralmedical@gmail.com 09 360 0250 Disclosures

More information

How to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP?

How to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP? 4 What is PrEP? 6 Who will benefit from PrEP? 7 Men (cis or trans) and trans women who have sex with men Partners of people living with HIV 8 Take the quiz: Is PrEP right for me? What are the options for

More information

Drug development in relation to PrEP and the PROUD study

Drug development in relation to PrEP and the PROUD study Drug development in relation to PrEP and the PROUD study David Dolling Medical Statistician MRC Clinical Trials Unit 18 th October 2012 What is PrEP? - Pre-exposure Prophylaxis A strategy that uses antiretrovirals

More information

HIV Treatment as Prevention (TasP)

HIV Treatment as Prevention (TasP) HIV Treatment as Prevention (TasP) Last updated: April 3, 2019 Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Treatment as Prevention?

More information

Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations

Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations Kevin Ard, MD, MPH Brigham and Women s Hospital The Fenway Institute Boston, MA Funding: The New England

More information

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013 Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013 Community Education Team The AIDS Institute/AIDS Alliance Be the Generation to End the AIDS Epidemic bethegeneration.nih.gov www.aids-alliance.org/education/vaccine

More information

PrEP for Women: HIV Prevention in Family Planning Settings

PrEP for Women: HIV Prevention in Family Planning Settings National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention PrEP for Women: HIV Prevention in Family Planning Settings Dawn K. Smith, MD, MS, MPH Division of HIV/AIDS Prevention dsmith1@cdc.gov

More information

Chart Pack National Survey of Young Adults on HIV/AIDS

Chart Pack National Survey of Young Adults on HIV/AIDS Chart Pack 2017 National Survey of Young Adults on HIV/AIDS November 30, 2017 Community and Personal Concern about HIV/AIDS How serious of a concern is HIV/AIDS for people you know? White Black Latino

More information

A Daily Pill to Prevent HIV: Oral Pre-exposure Prophylaxis (PrEP)

A Daily Pill to Prevent HIV: Oral Pre-exposure Prophylaxis (PrEP) A Daily Pill to Prevent HIV: Oral Pre-exposure Prophylaxis (PrEP) Delivette Castor, PhD USAID Jason Reed, MD, MPH Jhpiego Timothy Mah, DSc USAID Global Health Mini-University September 14, 2017 Presentation

More information

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner

More information

PrEP: Pre Exposure Prophylaxis

PrEP: Pre Exposure Prophylaxis PrEP: Pre Exposure Prophylaxis Lyn Stevens, NP, MS, ACRN Deputy Director Office of the Medical Director NYS Department of Health, AIDS Institute Faculty Disclosure Lyn Stevens No relationships to disclose

More information

HIV Reproductive Health: Conception Options in the Era of PrEP

HIV Reproductive Health: Conception Options in the Era of PrEP HIV Reproductive Health: Conception Options in the Era of PrEP Meg Sullivan, MD Director, HIV Clinical Programs, Section of Infectious Diseases Boston Medical Center Boston University School of Medicine

More information

Pre-Exposure Prophylaxis (PrEP) Stefanie La Manna, PhD, MPH, APRN, FNP-C, AGACNP-BC October 12, 2018

Pre-Exposure Prophylaxis (PrEP) Stefanie La Manna, PhD, MPH, APRN, FNP-C, AGACNP-BC October 12, 2018 Pre-Exposure Prophylaxis (PrEP) Stefanie La Manna, PhD, MPH, APRN, FNP-C, AGACNP-BC October 12, 2018 Disclosures I have no financial disclosures to report Objectives Identify the need for HIV prevention

More information

PEP, PREP, HPTN052 and MLN2238

PEP, PREP, HPTN052 and MLN2238 PEP, PREP, HPTN052 and MLN2238 Understanding the alphabet soup of HIV prevention and cure strategies Christina G Rivera, PharmD, BCPS Pharmacy Grand Rounds August 15, 2017 2017 MFMER slide-1 Presentation

More information

INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION

INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES WHO guidelines [EXECUTIVE SUMMARY] NDoH PrEP policy [FULL] NDoH PrEP guidelines [FULL] FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION

More information

CONTENTS. New Zealand s personal importation scheme for medicines. What is PrEP? Who will benefit from PrEP? Sex between men

CONTENTS. New Zealand s personal importation scheme for medicines. What is PrEP? Who will benefit from PrEP? Sex between men CONTENTS 4 What is PrEP? 6 Who will benefit from PrEP? Sex between men 7 Sex between men and women 8 What happens when I start on PrEP? 9 What if I want to stop using PrEP? Where can I get PrEP in New

More information

DEPARTMENT OF GENITO-URINARY MEDICINE HEPATITIS B

DEPARTMENT OF GENITO-URINARY MEDICINE HEPATITIS B DEPARTMENT OF GENITO-URINARY MEDICINE MAIN TRANSMISSION ROUTES HEPATITIS B Sexual transmission Occurs in unvaccinated/non immune men who have sex with men and correlates with multiple partners, unprotected

More information

REVIEW OF PREP GUIDELINES: A PRIMER FOR THE PRIMARY CARE PRACTITIONER ANTONIO E. URBINA, MD. PrEP Webinar Series

REVIEW OF PREP GUIDELINES: A PRIMER FOR THE PRIMARY CARE PRACTITIONER ANTONIO E. URBINA, MD. PrEP Webinar Series REVIEW OF PREP GUIDELINES: A PRIMER FOR THE PRIMARY CARE PRACTITIONER ANTONIO E. URBINA, MD PrEP Webinar Series Disclosure Speaker s Bureau: Gilead, VIIV, BMS, Merck, Serono LEARNING OBJECTIVES: 1. Review

More information

Counseling and Testing for HIV. Protocol Booklet

Counseling and Testing for HIV. Protocol Booklet Counseling and Testing for HIV Protocol Booklet JHPIEGO, an affiliate of Johns Hopkins University, builds global and local partnerships to enhance the quality of health care services for women and families

More information

SFAF CLINICAL PROTOCOLS

SFAF CLINICAL PROTOCOLS SFAF CLINICAL PROTOCOLS Page 1 of Supersedes Date: December 31, 2016 Original Date: August 20, 2014 Version: 03 Policy Section: Patient Care Non-Occupational Post Exposure Prophylaxis Program Back ground:

More information

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland An update for registered practitioners November 2017 Rationale for resource This resource is designed to support registered practitioners involved in

More information

Testing for HIV in Practice - Seminar. Case History. 19 year old black African patient registered with the practice 5 years (since age 14).

Testing for HIV in Practice - Seminar. Case History. 19 year old black African patient registered with the practice 5 years (since age 14). Joint RCGP / BHIVA Multidisciplinary Conference HIV in Primary Care: All you need to know Friday 25 January 2013 Friday 25 January 2013, Royal College of General Practitioners, London HIV in Primary Care

More information

Moving beyond condoms to prevent HIV transmission. Are you Prepared for HIV PrEP?

Moving beyond condoms to prevent HIV transmission. Are you Prepared for HIV PrEP? Moving beyond condoms to prevent HIV transmission Are you Prepared for HIV PrEP? The Issues New HIV infections in the US continue Vast majority of infections are sexually acquired Condoms work but are

More information

-decreased bone Adherence iprex study. -protective effect

-decreased bone Adherence iprex study. -protective effect HIV Pre-Exposure Prophylaxi is (PrEP): A brief guide for providers Daily emtricitabine/tenofovir (Truvada ) is safe and effectivee for reducing the risk of HIV acquisition in sexually active men and women

More information

Implementation of PrEP in Kenya

Implementation of PrEP in Kenya Implementation of PrEP in Kenya National AIDs & STI Control Program Ministry of Health November 2017 HIV in Kenya Context Kenya has the world s fourth largest HIV burden, 1.5 million people living with

More information

Healthcare Worker Orientation Package on the Pre-exposure Prophylaxis

Healthcare Worker Orientation Package on the Pre-exposure Prophylaxis Healthcare Worker Orientation Package on the Pre-exposure Prophylaxis Participant s Manual Participant s Manual Healthcare Worker Orientation Package on the Pre-exposure Prophylaxis 1 Healthcare Worker

More information

Adolescents Living with HIV

Adolescents Living with HIV Adolescents Living with HIV Gary Reubenson Polokwane 22 August 2015 Conflicts of Interest No relevant conflicts of interest to declare Acknowledgements Karl Technau Lee Fairlie Gill Sorour HIV Clinicians

More information

Guidelines for PrEP in PWID

Guidelines for PrEP in PWID Guidelines for PrEP in PWID Any use of injection drugs (past 6 months) AND Any sharing of injection equipment OR participation in methadone, naloxone, or buprenorphine treatment program (past 6 months)

More information

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention Dawn K. Smith, MD, MS, MPH Centers for Disease Control and Prevention The findings and conclusions in this presentation have not been formally

More information

Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically -

Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically - ASK SCREEN Test for HIV and STI Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically - Routinely obtain a thorough sexual history from all

More information

People who experience gender based violence are more at risk of HIV.

People who experience gender based violence are more at risk of HIV. Know the HIV risk People who experience gender based violence are more at risk of HIV. HIV Human Immunodeficiency Virus is the virus that causes AIDS by interfering with the body s ability to fight off

More information

Anti Retroviral Traitment (ARVs)

Anti Retroviral Traitment (ARVs) Anti Retroviral Traitment (ARVs) IEC material for People With Disabilities UPHLS - 2015 - Anti Retroviral Traitment Booklet Produced by AZ MEDIA No part of this publication may be reproduced without prior

More information

PrEP 201: Beyond the Basics

PrEP 201: Beyond the Basics NORTHWEST AIDS EDUCATION AND TRAINING CENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington February 19, 2015 Disclosures and Disclaimers I

More information

Using anti-hiv drugs for prevention

Using anti-hiv drugs for prevention Using anti-hiv drugs for prevention Highlights from AIDS 2012 (and 2 nd International Workshops on Treatment as Prevention) Tim Rogers, trogers@catie.ca Using anti-hiv Drugs for Prevention Outline Treatment

More information

Informed Consent Flipchart. Version 1.0, 30 Jan 2018

Informed Consent Flipchart. Version 1.0, 30 Jan 2018 Informed Consent Flipchart Version 1.0, 30 Jan 2018 Knowledge is Power Did you know? Across the world, young women are at high risk of getting HIV. In Africa, more than half of people living with HIV are

More information

MEDICAL MALE CIRCUMCISION. A discussion tool

MEDICAL MALE CIRCUMCISION. A discussion tool MEDICAL MALE CIRCUMCISION A discussion tool About the MMC Discussion Tool Learn and talk about Medical Male Circumcision with this exciting learning tool. It consists of a 15-minute DVD, which tells the

More information

HIV Pre-Exposure Prophylaxis (PrEP)

HIV Pre-Exposure Prophylaxis (PrEP) HIV Pre-Exposure Prophylaxis (PrEP) A Crash Course For General Practitioners Vincent Cornelisse BSc(Hons) MBBS FRACGP FAChSHM(RACP) Sexual Health Physician Prahran Market Clinic & Melbourne Sexual Health

More information

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination Be PrEPared! Using PrEP as Harm Reduction Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination Ricky Hill, MA, PhD candidate Team Lead, Community Partnerships and Engagement

More information

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe Sexually Transmitted Infections in Vulnerable Groups Kevin Rebe Definition: Key Populations Key populations are: Defined groups who, due to specific higher-risk behaviours, are at increased Men risk who

More information

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention New and Emerging Biomedical HIV Prevention Interventions Vaccines Vaginal microbicides Pre-exposure

More information

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE Clinical Education Initiative Support@ceitraining.org HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS Speaker: Susan MK Lee, PharmD, BCPS, CDE 12/13/2016 HIV Prevention with Pre-Exposure

More information

PrEP Home Checklist v1.0

PrEP Home Checklist v1.0 PrEP Home Checklist v1.0 Every Visit o Risk Reduction Counseling o Appropriate referrals and follow-ups (SW, Pharmacy, et al.) o For those on PrEP: o Assessment of PrEP adherence, side effects, ongoing

More information

PrEP and npep for HIV Prevention. Harry Rosado-Santos MD, FACP Associate Professor UU School of Medicine

PrEP and npep for HIV Prevention. Harry Rosado-Santos MD, FACP Associate Professor UU School of Medicine PrEP and npep for HIV Prevention Harry Rosado-Santos MD, FACP Associate Professor UU School of Medicine Case Study A 26 y/o M presents for routine asymptomatic screening for sexually transmitted infections

More information

Contraception for Women and Couples with HIV. Knowledge Test

Contraception for Women and Couples with HIV. Knowledge Test Contraception for Women and Couples with HIV Knowledge Test Instructions: For each question below, check/tick all responses that apply. 1. Which statements accurately describe the impact of HIV/AIDS in

More information

For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception

For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception FOR PEOPLE WHO HAVE BEEN SEXUALLY ASSAULTED What You Need to Know about STDs and Emergency Contraception

More information

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world? Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world? Lut Van Damme 11 Oct 2012 1 Disclaimer Gilead donated the study product for the FEM-PrEP trial I participated

More information

THE POWER OF UNDETECTABLE. What you need to know about HIV treatment as prevention

THE POWER OF UNDETECTABLE. What you need to know about HIV treatment as prevention THE POWER OF UNDETECTABLE What you need to know about HIV treatment as prevention CONTENTS 3 Treatment as prevention First, a few basics: What is an undetectable viral load? How do I know if I m undetectable?

More information

HIV. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV. Brief History of HIV AIDS. Global HIV Infection.

HIV. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV. Brief History of HIV AIDS. Global HIV Infection. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV HIV Sarah Kemink, PharmD, AAHIVP WMSHP Spring Seminar 5/05/2015 AIDS CD4 less than 200 +/- AIDS-defining illness Most common: Candidiasis

More information

Pre-Exposure Prophylaxis: The New Frontier of Prophylaxis Against HIV Infection

Pre-Exposure Prophylaxis: The New Frontier of Prophylaxis Against HIV Infection Pre-Exposure Prophylaxis: The New Frontier of Prophylaxis Against HIV Infection William F. Ryan Community Health Network PrEP Network Coordinator: Trevor Hedberg, MPH, CPH Supervising Health Educator:

More information

Arizona State Office of Rural Health Webinar Series

Arizona State Office of Rural Health Webinar Series Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording

More information

Australian Research Centre in Sex, Health & Society. EMBARGOED until am 4/8/09 Secondary Students and Sexual Health 2008

Australian Research Centre in Sex, Health & Society. EMBARGOED until am 4/8/09 Secondary Students and Sexual Health 2008 Australian Research Centre in Sex, Health & Society EMBARGOED until 10.30 am 4/8/09 Secondary Students and Sexual Health 2008 Melbourne, Australia Sample 2002 2008 Jurisdictions All All School sectors

More information

Guidelines on safer conception in fertile HIV infected individuals

Guidelines on safer conception in fertile HIV infected individuals Guidelines on safer conception in fertile HIV infected individuals couples Vivian Black Co-authors: L-G Bekker, H Rees, S Black, D Cooper, S Mall, C Mnyami, F Conradie, I Mahabeer, L Gilbert, S Schwartz,

More information

rated sexy smart safe Women Sexy, Smart & Safe

rated sexy smart safe Women Sexy, Smart & Safe rated sexy smart safe Women Sexy, Smart & Safe User Instructions These cards were designed to facilitate small group dialog and education on sexually transmitted infections (STIs) and HIV and AIDS. They

More information

Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials:

Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials: Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials: Rationale, Designs & Issues Connie Celum, MD, MPH Patrick Ndase, MBChB, MPH May 2007 Regional MTN Meeting Importance of HIV prevention Antiretroviral

More information

Pre-Exposure Prophylaxis (PrEP) for HIV Infection

Pre-Exposure Prophylaxis (PrEP) for HIV Infection Pre-Exposure Prophylaxis (PrEP) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research

More information

HIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO. Brent K. Sugimoto, MD, MPH Kaiser Permanente. 29th Annual East Bay HIV Update June 3, 2016

HIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO. Brent K. Sugimoto, MD, MPH Kaiser Permanente. 29th Annual East Bay HIV Update June 3, 2016 HIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO 29th Annual East Bay HIV Update June 3, 2016 Brent K. Sugimoto, MD, MPH Kaiser Permanente Photo Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith,

More information

Revised MEN S ATTITUDE SURVEY (the RMAS)

Revised MEN S ATTITUDE SURVEY (the RMAS) VISIT #: Visit Date: As before, this questionnaire is intended to assess and track your attitudes, beliefs and other factors that might influence your sexual and other risky or risk-reduction practices

More information

Multiple choice questions: ANSWERS

Multiple choice questions: ANSWERS Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible

More information

WESTERN CAPE ART GUIDELINES PRESENTATION 2013

WESTERN CAPE ART GUIDELINES PRESENTATION 2013 WESTERN CAPE ART GUIDELINES PRESENTATION 2013 The WC guidelines are based on SA National ART guidelines dated 24th March 2013 Acknowledgement goes to members of the Adult and Paediatric HAST policy advisory

More information

Clinical Management Guidelines 2012

Clinical Management Guidelines 2012 Central American Course Monitoring and Evaluation for HIV/AIDS Policy and Program Management 1 2 3 4 Module 1 Unit 1 Clinical Management Guidelines 2012 National TB, HIV/AIDS & other STIs Programme Ministry

More information

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments There are two options for accessing the audio portion of this webinar: (1) Using your

More information

Living Positively with HIV

Living Positively with HIV Living Positively with HIV Pregnancy and Planning a Family How do I avoid pregnancy and STI? What is this booklet for? This booklet gives basic information about planning a family if you are living with

More information